Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo. (2011)

First Author: Britland S

Attributed to: DPFS Devolved Portfolio (Pilot) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/btpr.587

PubMed Identifier: 21509949

Publication URI: http://europepmc.org/abstract/MED/21509949

Type: Journal Article/Review

Volume: 27

Parent Publication: Biotechnology progress

Issue: 3

ISSN: 1520-6033